11:20 AM EDT, 08/27/2024 (MT Newswires) -- European equities traded in the US as American depositary receipts were higher late Tuesday morning, rising 0.38% to 1,473.37 on the S&P Europe Select ADR Index.

From continental Europe, the gainers were led by financial services company Banco Santander (SAN), which rose 2.9%, followed by brewing company Anheuser-Busch InBev ( BUD ) , biopharmaceutical company Grifols ( GRFS ) , and financial services company ING (ING), which were up about 0.9% each.

The decliners from continental Europe were led by internet advertising firm Criteo ( CRTO ) and furniture maker Natuzzi (NTZ), which were down 2.1% and 1.7% respectively.

From the UK and Ireland, the gainers were led by biotech firm Trinity Biotech ( TRIB ) and biopharmaceutical company NuCana ( NCNA ) , which rose 41% and 8% respectively. They were followed by biopharmaceutical companies Akari Therapeutics ( AKTX ) and TC Biopharm ( TCBP ) , which were up 4.2% and 2.7% respectively.

The decliners from the UK and Ireland were led by biopharmaceutical companies Adaptimmune Therapeutics ( ADAP ) and Biodexa Pharmaceuticals ( BDRX ) , which lost 3.4% and 1.8% respectively. They were followed by biotech firm Autolus Therapeutics ( AUTL ) and biopharmaceutical company Mereo BioPharma Group ( MREO ) , which fell 1.6% and 1.3% respectively.